TrialMolecular cancer2022

On-treatment blood TMB as predictors for camrelizumab plus chemotherapy in advanced lung squamous cell carcinoma: biomarker analysis of a phase III trial.

Tao Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.